1-7 of 7
Keywords: Free testosterone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Associations of Pretreatment Serum Total Testosterone Measurements with Pathology-Detected Gleason Score Cancer

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Aldo Petrozziello, Claudio Ghimenton, Filippo Migliorini, Teodoro Sava, Beatrice Caruso, Mario Romano, Stefano Cavalleri, Walter Artibani
Journal: Urologia Internationalis
Urol Int (2014) 93 (3): 269–278.
https://doi.org/10.1159/000354621
Published Online: 11 December 2013
... Gleason score (pGS). Materials and Methods: Pretreatment and pathological variables of 220 patients operated with radical prostatectomy were retrospectively reviewed. Age, prostate-specific antigen (PSA), percentage of positive biopsy cores (P+), biopsy Gleason score (bGS), pGS, TT and free testosterone...
View article titled, Associations of Pretreatment Serum Total Testosterone Measurements with Pathology-Detected Gleason Score Cancer
Open the PDF for Associations of Pretreatment Serum Total Testosterone Measurements with Pathology-Detected Gleason Score Cancer in another window
Journal Articles

Serum Total Testosterone Is a Significant Preoperative Variable Independently Contributing to Separating the Prostate Cancer Population into Prostatectomy Gleason Score Groups

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Aldo Petrozziello, Claudio Ghimenton, Filippo Migliorini, Teodoro Sava, Beatrice Caruso, Claudio Cocco, Mario Romano, Stefano Cavalleri, Walter Artibani
Journal: Urologia Internationalis
Urol Int (2013) 91 (1): 55–61.
https://doi.org/10.1159/000350250
Published Online: 05 June 2013
... treatment. The patient population was grouped according to the pGS as 6 = 3+3, 7 = 3+4, 7 = 4+3 and 8-10. Eight variables were simultaneously investigated in each group: prostate-specific antigen (PSA), TT, free testosterone, age, percentage of positive prostate biopsy cores (P+), biopsy Gleason score (bGS...
View article titled, Serum Total Testosterone Is a Significant Preoperative Variable Independently Contributing to Separating the Prostate Cancer Population into Prostatectomy Gleason Score Groups
Open the PDF for Serum Total Testosterone Is a Significant Preoperative Variable Independently Contributing to Separating the Prostate Cancer Population into Prostatectomy Gleason Score Groups in another window
Journal Articles

Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Filippo Migliorini, Aldo Petrozziello, Teodoro Sava, Mario Romano, Beatrice Caruso, Claudio Cocco, Claudio Ghimenton, Stefano Zecchinini Antoniolli, Vincenzo Lacola, Emanuele Rubilotta, Carmelo Monaco, Luigi Comunale
Journal: Urologia Internationalis
Urol Int (2013) 90 (1): 45–55.
https://doi.org/10.1159/000343430
Published Online: 02 November 2012
...), luteinizing hormone (LH), FSH, prolactin hormone (PRL), total testosterone (TT), free testosterone (FT), estradiol (ESR) and PSA were the continuous variables. Category variables were pT and biopsy/pathology Gleason pattern I/II (b/pGPI/II). The population was clustered according to the FSH/PSA ratio which...
View article titled, Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy
Open the PDF for Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy in another window
Journal Articles

Investigative Clinical Study on Prostate Cancer Part VI: Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Filippo Migliorini, Aldo Petrozziello, Teodoro Sava, Mario Romano, Beatrice Caruso, Claudio Cocco, Claudio Ghimenton, Stefano Zecchinini Antoniolli, Vincenzo Lacola, Emanuele Rubilotta, Carmelo Monaco, Luigi Comunale
Journal: Urologia Internationalis
Urol Int (2012) 88 (2): 150–157.
https://doi.org/10.1159/000334596
Published Online: 23 December 2011
... with prostate cancer. Age, percentages of positive cores (P+) at transrectal ultrasound scan biopsy, biopsy Gleason score (bGS), luteinizing hormone (LH), FSH, total testosterone, free testosterone (FT) and prostate-specific antigen (PSA) were the continuous clinical variables. All patients had not previously...
View article titled, Investigative Clinical Study on Prostate Cancer Part VI: Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population
Open the PDF for Investigative Clinical Study on Prostate Cancer Part VI: Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population in another window
Journal Articles

Investigative Clinical Study on Prostate Cancer Part IV: Exploring Functional Relationships of Total Testosterone Predicting Free Testosterone and Total Prostate-Specific Antigen in Operated Prostate Cancer Patients

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Aldo Petrozziello, Filippo Migliorini, Vincenzo Lacola, Mario Romano, Teodoro Sava, Claudio Ghimenton, Beatrice Caruso, Stefano Zecchini Antoniolli, Emanuele Rubilotta, Carmelo Monaco, Luigi Comunale
Journal: Urologia Internationalis
Urol Int (2011) 86 (4): 399–406.
https://doi.org/10.1159/000324267
Published Online: 20 April 2011
... relationships of total testosterone (tt) predicting free testosterone (ft) and total PSA. Patients and Methods: 128 operated prostate cancer patients were simultaneously investigated for tt, ft and PSA before surgery. Patients were not receiving 5α-reductase inihibitors, LH-releasing hormone analogues...
View article titled, Investigative Clinical Study on Prostate Cancer Part IV: Exploring Functional Relationships of Total Testosterone Predicting Free Testosterone and Total Prostate-Specific Antigen in Operated Prostate Cancer Patients
Open the PDF for Investigative Clinical Study on Prostate Cancer Part IV: Exploring Functional Relationships of Total Testosterone Predicting Free Testosterone and Total Prostate-Specific Antigen in Operated Prostate Cancer Patients in another window
Journal Articles

Investigative Clinical Study on Prostate Cancer Part III: Exploring Total PSA and Free Testosterone Distributions and Linear Correlations in Groups and Subgroups of Operated Prostate Cancer Patients according to the Total PSA/FT Ratio

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Aldo Petrozziello, Mario Romano, Teodoro Sava, Claudio Ghimenton, Beatrice Caruso, Filippo Migliorini, Stefano Zecchini Antoniolli, Emanuele Rubilotta, Vincenzo Lacola, Carmelo Monaco, Luigi Comunale
Journal: Urologia Internationalis
Urol Int (2010) 85 (4): 406–409.
https://doi.org/10.1159/000319966
Published Online: 15 October 2010
.... The prostate-specific antigen/free testosterone (PSA/FT) ratio has been shown to be effective in clustering patients in prognostic groups as follows: low risk (PSA/FT ≤0.20), intermediate risk (PSA/FT >0.20 and ≤0.40) and high risk (PSA/FT >0.40 and ≤1.5). In the present study we explored the total PSA...
View article titled, Investigative Clinical Study on Prostate Cancer Part III: Exploring Total PSA and Free Testosterone Distributions and Linear Correlations in Groups and Subgroups of Operated Prostate Cancer Patients according to the Total PSA/FT Ratio
Open the PDF for Investigative Clinical Study on Prostate Cancer Part III: Exploring Total PSA and Free Testosterone Distributions and Linear Correlations in Groups and Subgroups of Operated Prostate Cancer Patients according to the Total PSA/FT Ratio in another window
Journal Articles

Investigative Clinical Study on Prostate Cancer Part II: On the Role of the Pretreatment Total PSA to Free Testosterone Ratio as a Marker Assessing Prostate Cancer Prognostic Groups after Radical Retropubic Prostatectomy

Available to Purchase
Subject Area:
Further Areas
Antonio B. Porcaro, Carmelo Monaco, Mario Romano, Aldo Petrozziello, Emanuele Rubilotta, Vincenzo Lacola, Teodoro Sava, Claudio Ghimenton, Beatrice Caruso, Stefano Zecchini Antoniolli, Filippo Migliorini, Luigi Comunale
Journal: Urologia Internationalis
Urol Int (2010) 85 (2): 152–158.
https://doi.org/10.1159/000318632
Published Online: 08 July 2010
...-specific antigen (PSA) to free testosterone (FT) ratio (PSA/FT) as a marker for assessing the pathologic Gleason sum (pGS) and levels of tumor extension (pT) in prostatectomy specimens. Patients and Methods: 128 of 135 consecutive patients diagnosed with prostate cancer underwent radical prostatectomy...
View article titled, Investigative Clinical Study on Prostate Cancer Part II: On the Role of the Pretreatment Total PSA to Free Testosterone Ratio as a Marker Assessing Prostate Cancer Prognostic Groups after Radical Retropubic Prostatectomy
Open the PDF for Investigative Clinical Study on Prostate Cancer Part II: On the Role of the Pretreatment Total PSA to Free Testosterone Ratio as a Marker Assessing Prostate Cancer Prognostic Groups after Radical Retropubic Prostatectomy in another window